Condition
Palmoplantar Keratoderma
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Recruiting1
Not Yet Recruiting1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06545695Phase 1Not Yet Recruiting
Epidermal Growth Factor Receptor Inhibition for Keratinopathies
NCT06561321Phase 2Active Not RecruitingPrimary
Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma
NCT05954416Recruiting
FARD (RaDiCo Cohort) (RaDiCo-FARD)
Showing all 3 trials